Truist Financial’s 89bio ETNB Stock Holding History

Truist Financial’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,000	Closed	-$246K	–	2731
2025 Q2	$246K	Buy	25,000 +15,000	+150%	+$124K	﹤0.01%	2314
2025 Q1	$72.7K	Buy	+10,000	New	+$87.4K	﹤0.01%	2459

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Truist Financial's ETNB Position: Q3 2025 in Review

Truist Financial sold out of 89bio (ETNB) in Q3 2025, closing a stake of 25,000 shares — an estimated $246K sold.

Truist Financial first reported a position in ETNB in Q1 2025 and held it in 2 quarters. The position peaked at $246K in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

Truist Financial reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
Truist Financial sold 25,000 89bio shares in Q3 2025, an estimated $246K.
Truist Financial first reported a position in 89bio in Q1 2025 and held it in 2 quarters.
Truist Financial's 89bio position peaked at $246K in Q2 2025.
198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Truist Financial's 13F filing for Q3 2025, filed 3 Nov 2025.